| (USD) | Sep 2017 | Y/Y change |
|---|---|---|
| Revenue | 13.87K | — |
| Operating expense | — | — |
| Net income | -1.36M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RGRX returned +250.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +133.3% |
| 1 year | +250.0% |
| 5 years | -100.0% |
| 10 years | -100.0% |
| All-time high | $415.00 (Jan 2005) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RGRX would be worth today ›No. RegeneRx Biopharmaceuticals, Inc. has not paid a dividend in the past 12 months.
RegeneRx Biopharmaceuticals, Inc. is part of the Healthcare sector.
RegeneRx Biopharmaceuticals, Inc. has a market cap of 1.05K USD, based on the latest quote.